Patent Expands Company's Proprietary Surface Acoustic Wave Platform into Advanced Therapeutic Delivery ApplicationsTYLER, ...
This biotech firm develops therapies for rare pulmonary diseases, leveraging proprietary drug delivery technology in the U.S.
Drug delivery devices and glucose sensors are smarter and smaller, and investigational devices are showing promise for type 2 ...
TriSalus Life Sciences Inc. (NASDAQ:TLSI) is one of the best fast growing penny stocks to buy right now. On May 4, TriSalus Life Sciences initiated patient enrollment for the PREDICTT clinical trial, ...
How reorganizing existing drugs and vaccine components can dramatically alter their potency, selectivity, and even their ...
ESTERO, FL / ACCESS Newswire / May 7, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), ...
In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi. Aside from the $750 million upfront payment, the deal also ...
Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...
Dr Shawn Davis is a passionate advocate for patients interacting less with their disease. In this interview, he talks about how that passion guides his work. How does your background in startups and ...
(RTTNews) - Monday, Merus N.V. (MRUS) has entered into a global non-exclusive collaboration and license agreement regarding Halozyme Therapeutics, Inc.'s ENHANZE drug delivery technology. Under the ...
ESTERO, FL / ACCESS Newswire / April 27, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results